Luis Aparicio

1.3k total citations
48 papers, 503 citations indexed

About

Luis Aparicio is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Luis Aparicio has authored 48 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Luis Aparicio's work include Prostate Cancer Treatment and Research (12 papers), Renal cell carcinoma treatment (8 papers) and Cancer Treatment and Pharmacology (7 papers). Luis Aparicio is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Renal cell carcinoma treatment (8 papers) and Cancer Treatment and Pharmacology (7 papers). Luis Aparicio collaborates with scholars based in Spain, United Kingdom and Italy. Luis Aparicio's co-authors include Rosario García Campelo, Enrique Grande Pulido, Javier Espinosa, M.R. García Campelo, Isabel Izarzugaza, Javier Marco, Ángel J. Lacave, J. Buesa, Javier Cassinello and Irina Fernandez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Luis Aparicio

45 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Aparicio Spain	15	213	204	163	90	65	48	503
Yu Peng China	12	148 0.7×	233 1.1×	231 1.4×	103 1.1×	64 1.0×	39	556
Assen Dudov Russia	9	217 1.0×	129 0.6×	208 1.3×	52 0.6×	111 1.7×	16	522
Suk‐young Lee South Korea	16	111 0.5×	395 1.9×	216 1.3×	148 1.6×	46 0.7×	43	719
Yeung Ho United States	12	248 1.2×	253 1.2×	123 0.8×	176 2.0×	23 0.4×	13	537
Xue‐cheng Bi China	15	165 0.8×	383 1.9×	216 1.3×	160 1.8×	94 1.4×	30	667
Ren Jie Jin United States	12	298 1.4×	339 1.7×	180 1.1×	178 2.0×	45 0.7×	17	640
Jinchul Kim South Korea	10	123 0.6×	243 1.2×	234 1.4×	159 1.8×	38 0.6×	31	633
Luise Maute Germany	11	130 0.6×	251 1.2×	136 0.8×	99 1.1×	23 0.4×	18	394
Ryo Sato Japan	11	115 0.5×	283 1.4×	289 1.8×	105 1.2×	44 0.7×	22	572
Li‐Hwa Wu Taiwan	9	98 0.5×	188 0.9×	236 1.4×	97 1.1×	65 1.0×	17	533

Countries citing papers authored by Luis Aparicio

Since Specialization

Citations

This map shows the geographic impact of Luis Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Aparicio more than expected).

Fields of papers citing papers by Luis Aparicio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Aparicio. The network helps show where Luis Aparicio may publish in the future.

Co-authorship network of co-authors of Luis Aparicio

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Aparicio. A scholar is included among the top collaborators of Luis Aparicio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Aparicio. Luis Aparicio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anido, Urbano, et al.. (2020). A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus. Clinical & Translational Oncology. 22(9). 1565–1579. 1 indexed citations

Gallardo, José M., et al.. (2019). Suelo-cemento-caliche como una solución sustentable a problemas geotécnicos. SHILAP Revista de lepidopterología. 4(2). 31–35.

Aparicio, Luis, Irina Fernandez, & Javier Cassinello. (2017). Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy. Clinical & Translational Oncology. 19(10). 1175–1182. 22 indexed citations

Anido, Urbano, et al.. (2015). Radium-223 dichloride: a new paradigm in the treatment of prostate cancer. Expert Review of Anticancer Therapy. 15(3). 339–348. 10 indexed citations

Vázquez‐Estévez, Sergio, et al.. (2013). Metastatic castration-resistant prostate cancer. Anti-Cancer Drugs. 25(3). 237–243. 15 indexed citations

Valladares‐Ayerbes, Manuel, et al.. (2012). Multiple biomarker tissue arrays: A computational approach to identifying protein-protein interactions in the EGFR/ERK signalling pathway. PubMed. 7(1). 14–14. 1 indexed citations

Valladares‐Ayerbes, Manuel, et al.. (2012). Searching for Hif1-α interacting proteins in renal cell carcinoma. Clinical & Translational Oncology. 14(9). 698–708. 13 indexed citations

Vázquez‐Estévez, Sergio, et al.. (2012). Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma. Advances in Therapy. 29(3). 202–217. 14 indexed citations

Bavbek, Sevil, Zafar Malik, Giuseppe Di Lorenzo, et al.. (2012). A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.. Journal of Clinical Oncology. 30(15_suppl). e15112–e15112. 3 indexed citations

10.

Valladares‐Ayerbes, Manuel, et al.. (2011). Relevant Networks involving the p53 Signalling Pathway in Renal Cell Carcinoma. International Journal of Biomedical Science. 7(4). 273–282. 1 indexed citations

11.

Campelo, M.R. García, et al.. (2011). Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clinical & Translational Oncology. 13(2). 77–83. 42 indexed citations

12.

Aparicio, Luis, et al.. (2011). Sunitinib-induced asthenia: From molecular basis to clinical relief. Cancer Biology & Therapy. 12(9). 765–771. 8 indexed citations

13.

Aparicio, Luis, et al.. (2010). Renal cell carcinoma: complete response. Anti-Cancer Drugs. 21(Supplement 1). S17–S18. 7 indexed citations

14.

Blanco, M., et al.. (2009). Comprehensive lung injury pathology induced by mTOR inhibitors. Clinical & Translational Oncology. 11(8). 499–510. 17 indexed citations

15.

Díaz‐Prado, Silvia, et al.. (2009). Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(1). 67–75. 22 indexed citations

16.

Díaz‐Prado, Silvia, et al.. (2008). Origin of renal cell carcinomas. Clinical & Translational Oncology. 10(11). 697–712. 20 indexed citations

17.

Maseda, Ana, et al.. (2007). Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia. Clinical & Translational Oncology. 9(5). 329–331. 5 indexed citations

18.

Aparicio, Luis, et al.. (2007). Prostate cancer and Hedgehog signalling pathway. Clinical & Translational Oncology. 9(7). 420–428. 16 indexed citations

19.

Campelo, Rosario García, et al.. (2007). Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. Clinical & Translational Oncology. 9(11). 694–702. 50 indexed citations

20.

Calvo, Lourdes, et al.. (2006). Subacute Cerebellar Degeneration as Paraneoplastic Syndrome: Initial Symptom of Breast Cancer with HER2 Overexpression. Clinical Breast Cancer. 7(1). 79–80. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact